Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

For decades, researchers have sought to develop a noninvasive method to measure blood glucose levels, which – if effective – could revolutionize diabetes care. One company in Israel now has such a device in development. Learn about the origins of this technology, its early success, and what this could mean for people with diabetes. Continue Reading »

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »

Full results from the SURPASS trials on the drug tirzepatide shows that this new medication dramatically lowers A1C and weight and is incredibly effective in people with type 2 diabetes. Read the latest from four clinical trials.  Continue Reading »

We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes. Continue Reading »

The discovery of insulin promised a new age for an ancient condition but introduced unexpected challenges. James S. Hirsch explores the riveting history of this miracle drug on its 100th anniversary. Continue Reading »

Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes and prediabetes. This new treatment has led to significant weight loss in clinical trials; expected to be available in the US this month. Continue Reading »

New results show that Vida Health’s digital diabetes coaching program led to meaningful reductions in A1C levels among people with type 2 diabetes, especially for those highly engaged with the program. Continue Reading »

From automated insulin delivery to therapeutic advances to glucose management during COVID-19, read our full coverage of one of the biggest international virtual diabetes conferences this year. Continue Reading »

Pages